Ingersoll Rand (India) declares interim dividend of ₹20 per share
Ingersoll Rand (India) (INGERRAND) said its board has declared a interim dividend of ₹20 per equity share. The company is valued at about ₹12,772 crore.
What happened
In a filing with the NSE on 6 November 2026 at 07:07 PM, Ingersoll Rand (India) (INGERRAND) said that its board has declared a interim dividend of ₹20 per equity share.
From the filing: "Ingersoll Rand (India) Limited has informed the Exchange that Board of Directors at its meeting held on November 06, 2026, declared Interim Dividend of Rs. 20 per equity share."
How big is it?
At the latest price of ₹4,045.8, the ₹20 payout amounts to 0.49% of the share price.
Company snapshot
Ingersoll Rand (India) is a small-cap company, with a market value of about ₹12,772 crore.
The stock last traded at ₹4,045.8, against a 52-week range of ₹3,063.3–₹4,955 (18.4% below the high).
Before this filing the shares had moved −2.6% over the month and −6.0% over three months. Average daily turnover over the last 20 sessions was about ₹4.1 crore.
Promoters held 75.00% at the end of Q1 FY27. Foreign institutions owned 1.28% and domestic institutions 8.97%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 315 | 59 | 18.68 |
| Q2 FY26 | 322 | 60.4 | 19.12 |
| Q3 FY26 | 455 | 71.9 | 22.77 |
| Q4 FY26 | 300 | 64.8 | 20.53 |
| Q1 FY27 | 379 | 70.5 | 22.32 |
What history shows
BCEIE's records show 1 previous dividend filing from the company since May 2026.
Market-wide, 1,005 dividend filings with an impact score of 50 or more saw an average next-day move of +0.1%, with 45% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- 6 November 2026: Board meeting — Financial Results/Dividend.
In the news
Recent coverage elsewhere (links open the original publisher):
- India EV Conclave 2026: Ingersoll Rand on the Technologies Transforming EV Manufacturing
- Ingersoll Rand acquires IVEK to expand life sciences unit By Investing.com
- Ingersoll Rand expands life sciences portfolio with acquisition of Ivek
- Ingersoll Rand 3Q 2026: Revenue $2.06B, Net income $669.9M, EPS $1.73— 10-Q Summary
- Ingersoll Rand buys precision-pump maker IVEK to grow life sciences
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.